Left ventricular hypertrophy: An overlooked cardiovascular risk factor

被引：51
|
作者：
Bauml, Michael A. [1 ]
Underwood, Donald A. [2 ]
机构：
[1] Cleveland Clin, Dept Internal Med, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 2010年 / 77卷 / 06期
关键词：
ESSENTIAL-HYPERTENSION; ELECTROCARDIOGRAPHIC DETECTION; PROGNOSTIC-SIGNIFICANCE; DECREASED INCIDENCE; MILD HYPERTENSION; MASS; ECHOCARDIOGRAPHY; REGRESSION; CRITERIA; EVENTS;
D O I：
10.3949/ccjm.77a.09158
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Left ventricular hypertrophy (LVH) is common in hypertensive patients, and it increases the risk of myocardial infarction, stroke, and death. Recent evidence indicates it is a modifiable risk factor that is not entirely dependent on blood pressure control. The authors review its pathogenesis, diagnosis, and treatment.
引用
收藏
页码：381 / 387
页数：7
相关论文
共 50 条
  • [31] LEFT-VENTRICULAR HYPERTROPHY AND CARDIOVASCULAR PROGNOSIS
    LAUER, MS
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 1995, 62 (03) : 169 - 175
  • [32] Correlations of left ventricular hypertrophy with cardiovascular mortality
    Sharpe, N
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, : 16 - 22
  • [33] Ventricular hypertrophy as a risk factor in ventricular septation for double-inlet left ventricle
    Nagashima, M
    Imai, Y
    Takanashi, Y
    Hoshino, S
    Seo, K
    Terada, M
    Aoki, M
    ANNALS OF THORACIC SURGERY, 1997, 64 (03): : 730 - 734
  • [34] Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy:: The LIFE study
    Wachtell, K
    Ibsen, H
    Olsen, MH
    Borch-Johnsen, K
    Lindholm, LH
    Mogensen, CE
    Dahlöf, B
    Devereux, RB
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Julius, S
    Kjeldsen, SE
    Kristianson, K
    Lederballe-Pedersen, O
    Nieminen, MS
    Okin, PM
    Omvik, P
    Oparil, S
    Wedel, H
    Snapinn, SM
    Aurup, P
    ANNALS OF INTERNAL MEDICINE, 2003, 139 (11) : 901 - 906
  • [35] Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy:: the LIFE study
    Reims, HM
    Kjeldsen, SE
    Brady, WE
    Dahlöf, B
    Devereux, RB
    Julius, S
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristianson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    JOURNAL OF HUMAN HYPERTENSION, 2004, 18 (06) : 381 - 389
  • [36] Left ventricular hypertrophy and cardiovascular risk factors in children with chronic renal disease
    Zamora, I.
    Sanahuja, M. J.
    Cano, A.
    Ortega, P.
    Roman, E.
    PEDIATRIC NEPHROLOGY, 2008, 23 (08) : 1387 - 1387
  • [37] LEFT VENTRICULAR HYPERTROPHY AND SUBSEQUENT CARDIOVASCULAR RISK: DOES IT MATTER HOW IT IS DIAGNOSED?
    Pareek, Manan
    Fletcher, Evan
    Vaduganathan, Muthiah
    Bhatt, Deepak L.
    Petersen, Soren S.
    Pedersen, Line R.
    Leosdottir, Margret
    Olsen, Michael H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 909 - 909
  • [38] Concentric left Ventricular Hypertrophy as an Early Marker of Cardiovascular Risk in Resistant Hypertension
    Figueiredo, V. N.
    Silva, T. Q. A. C.
    Gazzoto Filho, A.
    Pereira, D.
    Moreira, M. M.
    Martin, J. F., V
    Toledo, J. C. Y.
    Pires, N. F.
    Sultano, S.
    Moreno Jr, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (03) : 22 - 23
  • [39] Detection of left ventricular hypertrophy during the assessment of cardiovascular risk in hypertensive patients
    Domenech, Monica
    Coca, Antonio
    MEDICINA CLINICA, 2014, 142 (06): : 253 - 254
  • [40] Electrocardiographic left ventricular hypertrophy and the risk of adverse cardiovascular events: A critical appraisal
    Rautaharju, Pentti M.
    Soliman, Elsayed Z.
    JOURNAL OF ELECTROCARDIOLOGY, 2014, 47 (05) : 649 - 654
12345